Aaron Pelta
Corporate Officer/Principal en MORPHIC HOLDING, INC. .
Cargos activos de Aaron Pelta
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MORPHIC HOLDING, INC. | Corporate Officer/Principal | 01/01/2019 | - |
Historial de carrera de Aaron Pelta
Antiguos cargos conocidos de Aaron Pelta.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| X4 Pharmaceuticals (Austria) GmbH | Corporate Officer/Principal | 01/08/2016 | 01/03/2019 |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 18/06/2015 | 01/11/2015 |
Formación de Aaron Pelta.
| Tufts University | Undergraduate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Austria | 2 |
Operativa
| Corporate Officer/Principal | 3 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MORPHIC HOLDING, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
| X4 Pharmaceuticals (Austria) GmbH |
- Bolsa de valores
- Insiders
- Aaron Pelta
- Experiencia
